相关实验视频
Updated: Jul 11, 2025

04:44
Developing a Rat Model for Bipolar Disorder
Published on: May 2, 2025
285
作为双相情感障碍的精神药理学目标的黑素MT1受体:一个翻译性研究
Margherita Tassan Mazzocco1, Claudia Pisanu2, Luigi Russo3
1IRCCS San Raffaele Scientific Institute, Milan, Italy; School of Medicine, Vita Salute San Raffaele University, Milan, Italy.
Pharmacological research
|November 16, 2023
概括
通过UCM871激活黑色素受体1 (MT1) 显示出治疗双相情感障碍 (BD) 的潜力. 这项研究将MT1受体变异和黑激素水平与BD患者的躁狂发作联系起来.
科学领域:
- 神经科学是一个神经科学.
- 心理药理学 心理药理学
- 遗传学 是一个遗传学.
背景情况:
- 双极性障碍 (BD) 的治疗仍然具有挑战性,昼夜节律功能障碍是关键特征.
- 黑色素 (MLT) 通过MT1和MT2受体调节昼夜节律,这表明它在BD病理生理学中发挥作用.
研究的目的:
- 研究MT1受体在双相情感障碍中的作用和治疗潜力.
- 探索MT1受体激活对躁狂的小鼠模型和BD患者的影响.
主要方法:
- 用了一个钟表突变鼠标模型用于BD mania.
- 在行为和电生理学研究中服用UCM871,一种选择性MT1部分激动剂.
- 在隔离膜上进行高分辨率核磁共振 (NMR).
- 在一群BD患者中分析了MT1和CLOCK基因中的遗传变异.
主要成果:
- UCM871在ClockΔ19小鼠中逆转了行为和电生理学异常.
- 证明UCM871可以促进MT1受体的激活状态.
- 在严重躁狂发作,MLT水平和MT1 rs2165666遗传变异之间发现了显著的关联.
结论:
- MT1受体激活显示出双相情感障碍的治疗潜力.
- 这些发现支持MT1受体作为新型BD治疗的可行标.
相关概念视频
Management of Insomnia
257
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
257
Mania and Antimanic Drugs: Overview
198
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
198
Bipolar Disorder
67
Bipolar disorder is a chronic mental health condition marked by significant mood fluctuations, including episodes of mania and depression. Elevated energy levels, heightened mood or irritability, impulsive behavior, reduced sleep needs, rapid speech, racing thoughts, inflated self-esteem, and distractibility characterize mania. Individuals with bipolar disorder often alternate between depressive and manic states, with periods of emotional stability lasting an average of six months to a year.
67
Sedatives and Hypnotics Drugs: Miscellaneous Agents
180
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
180
Antidepressant Drugs: MAOIs and Other Agents
248
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
248
G-protein Coupled Receptors
119.8K
G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.
119.8K

